RxDoctor Payments Data

Navneet Virk Hundal

Pediatric Gastroenterology · Boston, MANPI 1972758068

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $930 of the $1,321 with a category attached, or 70.4%. AstraZeneca accounts for 97.8% of it on its own, with 1 other manufacturer making up the rest.

$1,321in general payments, 2019–2025

Across 10 payments — averaging $132.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Bristol Myers Squibb$29
$1,031,921in research payments, 2019–2025

Across 159 payments — averaging $6490.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$882K
  • AstraZeneca$131K
  • Bristol Myers Squibb$19K

What the payments were for

  • Travel & lodging$93070%
  • Food & beverage$39130%

General payments by program year

20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca9$1,292
Bristol Myers Squibb1$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,321 in reported general payments places this provider in the 65th percentile of 71 pediatric gastroenterology providers in Massachusetts.

See all pediatric gastroenterology providers in Massachusetts

Other pediatric gastroenterology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →